Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedivoxRx Technologies is a medical technology company focused on improving medication adherence through innovative assistive devices. The company's flagship product, Rex the Talking Pill Bottle, is a patented, reusable device designed to provide clear, audible instructions to patients who have difficulty reading standard prescription labels. Primarily targeting individuals with visual impairments, cognitive challenges, or low literacy, the technology helps prevent medication errors and promotes patient independence. MedivoxRx serves a niche but critical market within the healthcare sector, providing solutions to pharmacies and home care providers to enhance patient safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedivoxRx Technologies.